Skinbiotherapeutics Share Discussion Threads

[bobalot] 04/12/2017 12:04

GOOD NEW THOUGH FROM SKINBIO:

Catherine O'Neill, SkinBioTherapeutics’ chief executive, said: "The Australian skincare market is a key global market.

“The progression and successful grant of the first national patent to emerge from the company's Skinbiotix patent family underpins the commercial potential worldwide.

"This is a step forward in preparing for human trials, which are scheduled for 2018."

[bobalot] 04/12/2017 12:02

I shall explain...dipsticks often don't realise when they have something and yet nothing. THE OPTI MOB ARE RATHER LIKE THAT AND SO ARE YOU.

[1bokke] 04/12/2017 11:49

I have disturbing news and proof positive that Bobs posts are harmful... I read Bobs posts out loud and Oscar my beloved fish threw himself out of his tank.. Bob, all I have left is a box of water:'(

[bobalot] 04/12/2017 11:44

elrico 4 Dec '17 - 11:39 - 1072 of 1073 0 0 (Filtered)

complete and utter rubbish... you actually wrote reams about SBTX being a subsidiary.
An approach of discrediting others imo then the mob follow.

[bobalot] 04/12/2017 11:41

Selling the first product in China is most definitely on the cards..post patent registration. That's the largest market in the world and it happens to be upwardly mobile with a middle class population in excess of 500 million.


SBTX is planning global distribution through a big brand name imo.

The patent is in active prosecution in other locations worldwide including Europe, USA and China.

They all equate to the largest and more affluent population centres.

Everything is looking good so far for SBTX clinical and cosmetic creams imo.

[elrico] 04/12/2017 11:39

Slarty - I'm sure you're having fun with Bob, but alas, you are wasting your time. He is obviously one of those peeps that's NEVER WRONG. He is the type to HIT you in the rear and blame you for not jumping the red light. The simple fact is, OPTI only need 25% of SBTX share to effectively control it (assuming nobody with a greater number opposes) by BLOCKING ALL SPECIAL RESOLUTIONS SBTX seek to pass. OK, its limited control, to go a step further it could use its 41.9% and partner up with another investor to take full control in EXTREME cases. This is extremely unlikely, therefore a rather foolish argument Bob seems hell bent on bashing home...or so it would appear from one side of the debate.

The irony of it all is lost on Bob. His strategy is to become the PI voice to advocate the positives of SBTX and seeks to be the voice of authority. However, his basic errors only serve to undermine this and attacking OPTI bulls (many of which have already bought into the SBTX story) only serves to undermine his strategy even further. Simply crating an argument where non exists is folly.

[slartybartfaster] 04/12/2017 11:23

You are one sad thicko. Opti have 41.9%, we all agree sbtx is no longer a sub of opti so why keep bringing it up? Again you have the numbers wrong, it would be 51% or more not 50%.

Briefly set out the rights of minority shareholders and the shareholding required to exercise such rights.
Minority shareholders' rights vary depending on the percentage of shares/voting rights they hold in the company, as follows:
At least 5%: right to:
apply to court to prevent the conversion of a public company into a private company;
call a general meeting;
require the circulation of a written resolution to shareholders (in private companies); and
require the passing of a resolution at an annual general meeting (AGM) of a public company.
At least 10%: right to call for a poll vote on a resolution.
More than 10%: right to prevent a meeting being held on short notice (in private companies).
15%: right to apply to the court to cancel a variation of class rights, provided such shareholders did not consent to, or vote in favour of, the variation.
More than 25%: right to prevent the passing of a special resolution.

What are the voting requirements for passing resolutions at general meetings?
The voting requirements for passing resolutions at general meetings are as follows:
50% (a simple majority) of those attending and voting (in person or by proxy) for ordinary resolutions. Opti have 41.9% the single largest influential holding
75% of those attending and voting for special resolutions.



Bob you are a bigger fool than we already think if you think opti cannot control sbtx if they chose to do so. This is not the same as holding a direct controlling interest. Opti are in the box seat while it holds 41.9%.

[loungeact] 04/12/2017 11:22

NEWSFLASH FROM BOBALOT: Skinbiotheraputics have confidence in their product!

[bobalot] 04/12/2017 10:59

SBTX are showing incredible confidence in their products by pursing global patent rights ahead of human testing early next year -- perhaps they know it works and has a huge market potential in its current form.

[slartybartfaster] 02/12/2017 20:56

Can we have it again bob just in case we miss it.

[bobalot] 02/12/2017 20:25

Excellent news last Friday. As a concurrent exercise SBTX is preparing for a GLOBAL LAUNCH LATER NEXTT YEAR.

The patent is in active prosecution in other locations worldwide including Europe, USA and China.

Dr Catherine O'Neill, CEO of SkinBioTherapeutics, commented:

"The Australian skincare market is a key global market. The progression and successful grant of the first national patent to emerge from the Company's Skinbiotix(R) patent family underpins the commercial potential worldwide.

"This is a step forward in preparing for human trials, which are scheduled for 2018."

[bobalot] 02/12/2017 20:24

Focus on real news and not fake or misleading expectations touted as facts BY THE OPTI MOBSTERS.

[onedayrodders] 02/12/2017 18:38

So we have moved on from getting free shares to the actual ratio


;o)

[bobalot] 02/12/2017 13:21

ODR --- THAT WILL IMPROVE SKINBIO'S LIQUIDITY --- but don't expect free stock on a 1:1 ratio....more like 1:200 or 1:400.

At these prices its better to buy in direct without having to pay tax OR HAVING A LOCK IN PERIOD.

OPTI ARE ACTUALLY DEPLETING THEIR OWN VALUE BY THE WAY.

[elrico] 01/12/2017 20:40

Now, now Rodders...behave yourself. ;)

[onedayrodders] 01/12/2017 20:37

Great news today ... especially for OPTI holders who will soon get free SBTX shares

;o)

[bobalot] 01/12/2017 11:19

They all equate to the largest and more affluent population centres --- they will need a separate registration for India who have a more difficult process for patent awards. Which is still a bone of contention for Western big Pharams.

But everything is looking good so far for SBTX clinical and cosmetic creams imo.

[bobalot] 01/12/2017 10:59

IN TODAYS RNS ALONG WITH THE USA and others....SBTX is planning global distribution through a big brand name imo.

The patent is in active prosecution in other locations worldwide including Europe, USA and China.

[polus] 01/12/2017 10:19

Has China been mentioned anywhere?

[bobalot] 01/12/2017 09:32

Selling the first product in China is most definitely on the cards..post patent registration. That's the largest market in the world and it happens to be upwardly mobile with a middle class population in excess of 500 million.

[rathean] 01/12/2017 09:29

I like bob. He ramps my shares :)

[loungeact] 01/12/2017 09:06

Lol, oh bob..

[bobalot] 01/12/2017 09:05

The human trials will only take a month and after the extensive testing already done on live skin looks to be a formality to confirm results.